CN Patent
CN101175529A — 用于在组织中产生一氧化氮的可摄入装置
Assigned to Egypt Peel Pharmaceutical Co · Expires 2008-05-07 · 18y expired
What this patent protects
本发明提供一种包括可摄入装置(10)的设备,所述装置(10)包括两个或多个电极(22)、以及信号控制器(20),所述信号控制器设置为用于驱动电极(22)将电信号施加到对象胃肠(GI)道壁的内表面,并且设置所述信号来诱导一氧化氮(NO)的局部内源性释放。还描述了其它的实施方案。
USPTO Abstract
本发明提供一种包括可摄入装置(10)的设备,所述装置(10)包括两个或多个电极(22)、以及信号控制器(20),所述信号控制器设置为用于驱动电极(22)将电信号施加到对象胃肠(GI)道壁的内表面,并且设置所述信号来诱导一氧化氮(NO)的局部内源性释放。还描述了其它的实施方案。
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.